Search Page

1

Cite

Share

Dissolution testing of oral modified-release dosage forms.

Garbacz G, Klein S. Garbacz G, et al. J Pharm Pharmacol. 2012 Jul;64(7):944-68. doi: 10.1111/j.2042-7158.2012.01477.x. Epub 2012 Feb 21. J Pharm Pharmacol. 2012. PMID: 22686342 Review.

Cite

Share

2

Cite

Share

A novel open source tool for ELISA result analysis.

Danielak D, Banach G, Walaszczyk J, Romański M, Bawiec M, Paszkowska J, Zielińska M, Sczodrok J, Wiater M, Hoc D, Kołodziej B, Garbacz G. Danielak D, et al. Among authors: garbacz g. J Pharm Biomed Anal. 2020 Sep 10;189:113415. doi: 10.1016/j.jpba.2020.113415. Epub 2020 Jun 20. J Pharm Biomed Anal. 2020. PMID: 32574997 Free article.

Cite

Share

3

Cite

Share

Development of a Biphasic-Release Multiple-Unit Pellet System with Diclofenac Sodium Using Novel Calcium Phosphate-Based Starter Pellets.

Zakowiecki D, Frankiewicz M, Hess T, Cal K, Gajda M, Dabrowska J, Kubiak B, Paszkowska J, Wiater M, Hoc D, Garbacz G, Haznar-Garbacz D. Zakowiecki D, et al. Among authors: garbacz g. Pharmaceutics. 2021 May 28;13(6):805. doi: 10.3390/pharmaceutics13060805. Pharmaceutics. 2021. PMID: 34071381 Free PMC article.

Cite

Share

4

Cite

Share

Simulating the postprandial stomach: physiological considerations for dissolution and release testing.

Koziolek M, Garbacz G, Neumann M, Weitschies W. Koziolek M, et al. Among authors: garbacz g. Mol Pharm. 2013 May 6;10(5):1610-22. doi: 10.1021/mp300604u. Epub 2013 Apr 1. Mol Pharm. 2013. PMID: 23506381 Review.

Cite

Share

5

Cite

Share

The Effects of Various Food Products on Bisphosphonate's Availability.

Zielińska M, Garbacz G, Sczodrok J, Voelkel A. Zielińska M, et al. Among authors: garbacz g. Pharmaceutics. 2022 Mar 27;14(4):717. doi: 10.3390/pharmaceutics14040717. Pharmaceutics. 2022. PMID: 35456551 Free PMC article.

Cite

Share

6

Cite

Share

Simulating the postprandial stomach: biorelevant test methods for the estimation of intragastric drug dissolution.

Koziolek M, Garbacz G, Neumann M, Weitschies W. Koziolek M, et al. Among authors: garbacz g. Mol Pharm. 2013 Jun 3;10(6):2211-21. doi: 10.1021/mp300607e. Epub 2013 May 8. Mol Pharm. 2013. PMID: 23654347 Review.

Cite

Share

7

Cite

Share

A biorelevant dissolution stress test device - background and experiences.

Garbacz G, Klein S, Weitschies W. Garbacz G, et al. Expert Opin Drug Deliv. 2010 Nov;7(11):1251-61. doi: 10.1517/17425247.2010.527943. Expert Opin Drug Deliv. 2010. PMID: 20977290 Review.

Cite

Share

8

Cite

Share

Development and Bio-Predictive Evaluation of Biopharmaceutical Properties of Sustained-Release Tablets with a Novel GPR40 Agonist for a First-in-Human Clinical Trial.

Juszczyk E, Kisło K, Żero P, Tratkiewicz E, Wieczorek M, Paszkowska J, Banach G, Wiater M, Hoc D, Garbacz G, Sczodrok J, Danielak D. Juszczyk E, et al. Among authors: garbacz g. Pharmaceutics. 2021 May 28;13(6):804. doi: 10.3390/pharmaceutics13060804. Pharmaceutics. 2021. PMID: 34071286 Free PMC article.

Cite

Share

9

Cite

Share

Biorelevant In Vitro Release Testing and In Vivo Study of Extended-Release Niacin Hydrophilic Matrix Tablets.

Milanowski B, Hejduk A, Bawiec MA, Jakubowska E, Urbańska A, Wiśniewska A, Garbacz G, Lulek J. Milanowski B, et al. Among authors: garbacz g. AAPS PharmSciTech. 2020 Jan 27;21(3):83. doi: 10.1208/s12249-019-1600-z. AAPS PharmSciTech. 2020. PMID: 31989330 Free PMC article.

Cite

Share

10

Cite

Share

Physiologically Based Dissolution Testing in a Drug Development Process-a Case Study of a Successful Application in a Bioequivalence Study of Trazodone ER Formulations Under Fed Conditions.

Danielak D, Milanowski B, Wentowski K, Nogowska M, Kątny M, Rogowski P, Konwicki Ł, Puk E, Pieczuro J, Bawiec M, Garbacz G, Lulek J. Danielak D, et al. Among authors: garbacz g. AAPS PharmSciTech. 2020 Jun 2;21(5):161. doi: 10.1208/s12249-020-01662-8. AAPS PharmSciTech. 2020. PMID: 32488427 Free PMC article.

Cite

Share